Gufic BioSciences Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Bonus
• Share holding
• Capital structures
• Ratio

Mar ' 25	Mar ' 24	Mar ' 23	Mar ' 22	Mar ' 21

Sources of funds

Owner's fund

Equity share capital

10.03

10.03

9.69

9.69

9.69

Share application money

-

-

-

-

-

Preference share capital

-

-

-

-

-

Reserves & surplus

591.34

522.53

338.11

259.42

163.74

Loan funds

Secured loans

310.37

317.03

311.41

61.24

51.75

Unsecured loans

-

-

-

-

-

Total

911.74

849.60

659.22

330.36

225.19

Uses of funds

Fixed assets

Gross block

580.91

220.50

227.89

168.24

148.18

Less : revaluation reserve

-

-

-

-

-

Less : accumulated depreciation

74.92

61.61

68.32

53.07

48.21

Net block

505.99

158.89

159.57

115.17

99.97

Capital work-in-progress

21.82

307.06

169.59

40.87

13.40

Investments

2.81

1.79

0.78

0.01

0.01

Net current assets

Current assets, loans & advances

639.01

624.80

531.22

365.35

278.68

Less : current liabilities & provisions

257.89

242.95

201.94

191.04

166.87

Total net current assets

381.12

381.85

329.27

174.31

111.81

Miscellaneous expenses not written

-

-

-

-

-

Total

911.74

849.60

659.22

330.36

225.19

Notes:

Book value of unquoted investments

2.81

1.79

0.78

0.01

0.01

Market value of quoted investments

-

-

-

-

-

Contingent liabilities

6.89

11.80

27.87

100.51

16.20

Number of equity sharesoutstanding (Lacs)

1002.78

1002.78

969.45

969.45

969.45